Moving forward, longitudinal studies should examine whether early IL-17A deficiency correlates with subsequent immune-related outcomes in childhood, while mechanistic studies could explore the therapeutic potential of modulating IL-17A pathways in affected neonates. Here, IL17A is linked to hyperinsulinemic hypoglycemia, familial, 4.